InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: microcapbiotech post# 26763

Sunday, 06/23/2019 7:38:14 PM

Sunday, June 23, 2019 7:38:14 PM

Post# of 34625
Well, the presenting the data twice is not as convincing for the fact that it's a plenary session. A Plenary session takes place at the opening of a conference where all attendees are in one big room.

A regular presentation is broken up into several small rooms with participants. A plenary session is the cream of the crop so to say. It's like the Gold Medal of the Olympics. I don't believe AACR 2019 would have selected a plenary session presentation for bad data IMO.

Also, if the company had something bad to report they wouldn't wait to dilute. They filed their shelf offering. My hope is that MRKR will wait until after PC data, of course if it is very good, before diluting.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News